about
Envelope glycoprotein of arenavirusesStructural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site, 2: relevance of an N-terminal helix.Novel approaches in anti-arenaviral drug developmentAntiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease.Zymogen activation and subcellular activity of subtilisin kexin isozyme 1/site 1 protease.Synthetic peptides for study of human immunodeficiency virus infection.Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242.Synthetic peptides for AIDS research.Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease.A Molecular Sensor To Characterize Arenavirus Envelope Glycoprotein Cleavage by Subtilisin Kexin Isozyme 1/Site 1 ProteaseMechanism of Folding and Activation of Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P).The role of proteolytic processing and the stable signal peptide in expression of the Old World arenavirus envelope glycoprotein ectodomain.In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate.Differential recognition of Old World and New World arenavirus envelope glycoproteins by subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P).Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan.Role of DC-SIGN in Lassa virus entry into human dendritic cellsCurrent drug discovery strategies against arenavirus infections.Viral envelope glycoprotein processing by proprotein convertases.Novel drug discovery approaches for treating arenavirus infections.The proprotein convertase SKI-1/S1P. In vitro analysis of Lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors.Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1.Effects of the prosegment and pH on the activity of PCSK9: evidence for additional processing events.Studies of Lassa Virus Cell Entry.The lectin ERGIC-53 goes viral.Novel osteoblast-adhesive peptides for dental/orthopedic biomaterials.CCR5 N-terminus peptides enhance X4 HIV-1 infection by CXCR4 up-regulation.Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site 3: role of site-specific mutations.The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates.Arenavirus envelope glycoproteins mimic autoprocessing sites of the cellular proprotein convertase subtilisin kexin isozyme-1/site-1 protease.The H5N1 influenza variant Fujian-like hemagglutinin selected following vaccination exhibits a compromised furin cleavage : neurological Consequences of highly pathogenic Fujian H5N1 strains.Heparin enhances the furin cleavage of HIV-1 gp160 peptides.
P50
Q24613392-488D16BE-AC26-47A6-8E10-3509955FFE03Q30816306-84875A0A-23C5-40B4-A322-8BE9843C6E66Q33779739-36D452A6-7762-4729-B78E-77199E77253DQ34485294-E04490A6-D5D8-4E35-9117-B6C4BA4D2FB3Q34774433-4468CDD3-4DA2-4B3B-A3B3-9E31FC24F9B8Q34978659-9B02F5A9-BABC-423C-8ECB-CA468131FF1BQ35774829-957AE9B1-BB9F-4E92-A32D-D3B8E240B339Q35867163-1012099B-3D8A-4F60-B24D-733687B082F8Q35943805-D3F6E498-9E12-439E-9941-4F733550BBD8Q36434299-1277B1F3-D768-4EF5-859D-1A762CD273D3Q36518221-C476C5BF-7146-47B8-99DF-064A42AC3290Q36532761-D4F395AF-D803-4915-8441-1EFF633F0139Q36545901-708BB18E-86FE-44D3-8693-EDA1C26EAD60Q36827122-F6358155-94EF-4B8C-ADE3-9C28A81F7180Q37247060-641F33D2-9642-458B-936E-5D2F5F1E9292Q37252717-D0967615-5228-4AE3-9423-913C9D05C5CBQ38067504-7A90563D-42FD-4F52-9743-206606EFA9B9Q38101147-EE15D8BE-F32B-4F7A-A556-EDB049183F70Q38735837-4A1FD398-A3E2-4D55-ABD5-35DEC56AD459Q40264454-9E7FA864-2EF8-465F-9B99-CB9A19E70F5FQ40551750-8D8B6183-C6DF-40A4-99F1-65E1ABC1B9C2Q41198301-0B7F4D7C-153E-472A-A847-9AE633F6C7B6Q41922444-29F0A389-CF6D-4025-A294-96088CBF5F57Q42240509-8C6CC084-C8AF-4DD2-B54F-F4335F8374E9Q43938093-5AE70C9D-0D07-42E9-8BBE-03BDC7B26184Q44533979-7D3414E4-0E4B-4ACA-B816-BE30DC17F5A3Q45139143-415B45CB-6C56-441A-8E21-67B54501A459Q46881400-492028A3-CFB4-412B-98FB-E8E1BF41E0DFQ53245367-AF9A74AA-D871-4809-9352-3CF5A97B7E37Q53495526-D4A5BB1D-EF78-451A-BA15-370A82DB92C1Q53514545-6F274B28-69B0-4E8F-96C1-D011A2309533
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonella Pasquato
@ast
Antonella Pasquato
@en
Antonella Pasquato
@es
Antonella Pasquato
@nl
Antonella Pasquato
@sl
type
label
Antonella Pasquato
@ast
Antonella Pasquato
@en
Antonella Pasquato
@es
Antonella Pasquato
@nl
Antonella Pasquato
@sl
prefLabel
Antonella Pasquato
@ast
Antonella Pasquato
@en
Antonella Pasquato
@es
Antonella Pasquato
@nl
Antonella Pasquato
@sl
P106
P21
P31
P496
0000-0002-9428-0722